Therefore, BCRP can remove macrocyclic compounds such as pheophorbide a, protoporhyrin IX (PpIX), chlorin e6, or porphyrins, making BCRP-positive cancers a difficult target for PDT [64,65]. The gene discussed is ABCG2; the disease is cancer.